The Immuno sliver bullet; is Immunotherapy a “silver bullet” or is it hype?

Shared information is powerful it improves Outcomes
What do you think about this article ? can you add? do you know of other articles on this subject?

The Cancer, The “Silver Bullet” and The hype. Hope for the many is near!

Cholangiocarcinoma Australia is a Centralised Hub by patients and caregivers for Patients and Caregivers.
A sharable informational resource that connects and empowers.
“Better decision making options equals Better Outcomes”, regenerating patients purpose, direction and momentum – Saving lives.
Steve & Claire Holmes

Forward by Steve Holmes

The Immuno sliver bullet; is Immunotherapy a “silver bullet” or is it hype?

This is video attempts to create balance and remove hype – It does insert real hope on the near horizon. Keep an eye on the fast evolving topic of CAR-T Cells it could well be your Knight in Shining Armour in the near future. I hope this Video helps improve your decision making.

Regards your fellow Cholangio Crusader

The promise and limits of cancer immunotherapy

Published on Sep 13, 2018
Since its advent, there have been numerous conflicting reports about whether immunotherapy will be a “silver bullet” for different types of cancer, or if such expectations are based on hype or limited evidence. Many of the misconceptions about immunotherapy’s potential are due to our limited understanding of the immune system and how it serves to protect us from disease.

A pioneer in cancer care treatment, oncologist Lennie Sender has a deep understanding of both the possibilities and limitations of harnessing the immune system to treat different types of cancer. Check out Lennie’s 2017 TEDMED Talk for his straightforward report of the state of cancer immunotherapy options today and the promise they may hold for the future.

Also View
Using Your Own Body To Fight Cancer

TEDx Talks
By Wesley Wilson 

Published on Jan 17, 2018

In this talk, Wesley shares details on understanding how cancer works in order to develop new treatments and better practices. What is immunotherapy and could it open the door to treating aggressive and difficult to treat cancers? Could our own immune systems hold the clue for defeating these diseases? Wes is a Canadian cancer researcher working on developing new therapies and cancer treatments. He had the opportunity to work and study around the globe in 5 countries. His previous work has led to the understanding of gene expression changes as cancer progresses in brain tumours, the discovery of new pathways involved in the tumorigenesis of breast cancer, and development of new strategies in radiotherapy treatment. He also has a long history in the technology sector and serves as CTO of two medical technology companies in North America. He has received engineering and innovation awards for his work in health tech from Waterloo, Massachusetts Institute of Technology (MIT), Microsoft, and Intel. He continues to work on machine learning algorithms to produce new tools for the future of medicine. Wes currently lives in Perth, Western Australia, where he works at The University of Western Australia and Harry Perkins Institute of Medical Research. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at